U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The idea that cavalry will be replaced by these iron coaches is absurd. It is little short of treasonous."

Aide-de-camp to Field Marshal Haig ; At a tank demonstration, 1916

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: JUDY JARECKI-BLACK; PH.D., J.D.


Number of applications: 41
Last date: February 03, 2011

1    
Application No.Application TitleIssue Date
20110028495THE USE OF 6-HALOGENO-[1,2,4]-TRIAZOLO-[1,5-a]-PYRIMIDINE COMPOUNDS FOR COMBATING PESTS IN AND ON ANIMALS
The present invention relates to the use of 6-halogeno-[1,2,4]-triazolo[1,5-a]-pyrimidine compounds of the general formula I

    • ...
02/03/2011
20100298419ANTIBIOTIC-FREE PLASMID
The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The in...
11/25/2010
20100285066CANINE LEISHMANIA VACCINE
The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania
11/11/2010
20100261782INTRA-VASCULAR KIDNEY GENE THERAPY WITH PLASMID ENCODING BMP-7
The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic r...
10/14/2010
20100255029NEWCASTLE DISEASE VIRUS VECTORED AVIAN VACCINES
The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifi...
10/07/2010
20100226876COMPOSITION FOR CONTROLLING FISH
The present invention relates to a composition for controlling fish. In particular, the composition may be an incitant, functioning as either a fish attractant or a fish repellent. The composition may be prepared by extracting bacteria from a source fish, culturing the ...
09/09/2010
20100222288Stabilized Formulation of Ivermectin Feed Premix with an Extended Shelf Life and Method of Making the Same
The invention relates to a stabilized premix feed or feed-like formulation that has an extended shelf life due to a decrease of the degradates of the active ingredient by controlling the amount of an already existing stabilizer in the formulation. The feed premix is use...
09/02/2010
20100221282RECOMBINANT VACCINE AGAINST WEST NILE VIRUS
An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The...
09/02/2010
20100189731RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF
The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a subunit vaccine based on the hemagglutinin of influenza. The hemagglutinin may be expressed in plants including duckweed. The invention also encompasses re...
07/29/2010
20100145035METHOD OF SYNTHESIZING MACROLIDE COMPOUNDS
The present invention relates to methods for synthesizing macrolide compounds which are known to have antibacterial activity, and are useful in the therapy of bacterial infections in mammals. More specifically, the invention relates to methods for synthesizing the macro...
06/10/2010
20100144859DIMERIC AVERMECTIN AND MILBEMYCIN DERIVATIVES
This invention provides for novel antiparasitic and pesticidal derivatives of avermectin and milbemycin compounds in which two avermectin or milbemycin members are linked together by a chemical linker. The resulting compounds may be used in veterinary compositions which...
06/10/2010
20100143510INTRAMAMMARY TEAT SEALANT
The present invention relates to veterinary or pharmaceutical formulations comprising one or more plant oils and bismuth subnitrate and methods for their manufacture and uses. The formulations are useful as a teat sealant to prevent or treat mastitis in an animal....
06/10/2010
20100137384Anthelmintic Composition
The invention relates to a novel formulation having the advantage of including triclabendazole in solution. In addition a further anthelmintic may be included. The formulation is made by mixing the abamectin and benzyl alcohol and mixing this with triclabendazole and bu...
06/03/2010
20100130565THIOAMIDE COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF
The present invention relates to novel thioamide derivatives of formula (I) and formula (Ia):

wherein, R3, R4, R5, R6, R7, P, Q, T, V, W, X, Y, Z, a, m a...

05/27/2010
20100125097COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND/OR A FORMAMIDINE, METHODS AND USES THEREOF
This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds alone or in combination with formamidine compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite ...
05/20/2010
20100125089ENANTIOMERICALLY ENRICHED ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF
The present invention relates to novel aryloazol-2-yl-cyanoethylamino derivatives substantially enriched in an enantiomer of formula (I):

and compounds of formula (IH)

05/20/2010
20100125060FORMULATIONS COMPRISING CEFTIOFUR AND KETOPROFEN OR CEFTIOFUR AND BENZYL ALCOHOL
The present invention relates to veterinary or pharmaceutical formulations which may comprise ceftiofur, ketoprofen, benzyl alcohol, or effective combinations thereof. The formulations of the present invention may include a wetting or dispersing agent, a preservative, a...
05/20/2010
20100119546VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS
The present invention provides vectors that contain and express in vivo the genes encoding VP2 and VP5 of African Horse Sickness Virus or an epitope thereof that elicits an immune response in a horse against African horse sickness virus, compositions comprising said vec...
05/13/2010
20100062019NEW VACCINE FORMULATIONS
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified or weakly purified. The emulsion of the present invention can act as vehicl...
03/11/2010
20090324649LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN
The present invention provides vectors that contain and express in vivo or in vitro sand fly Lu. longipalpis salivary antigens that elicit an immune response in animal or human against Leishmania, vaccine compositions comprising said vectors and/or Lu. ...
12/31/2009
20090228319Breed-Specific Haplotypes for Polled Phenotypes in Cattle
The presence of horns within commercial cattle populations increases the chances of injuries. The Polled (hornless) condition in cattle has existed since domestication, and it has been selected by breeders because of its economic importance and ease of management. A dom...
09/10/2009
20090171297CONTAINER AND CAP ASSEMBLY
A substance delivery system may include a substance delivery device, a cap, and a removal device. The system may be designed for ease of use. The substance delivery device may include an elongated member adapted to interface with a body. Substance delivery devices may b...
07/02/2009
20090093427Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7
The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of osteoarthritis in mammal...
04/09/2009
20090082301GENE THERAPY FOR RENAL FAILURE
The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic r...
03/26/2009
20080312272ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF
The present invention relates to novel aryloazol-2-yl-cyanoethylamino derivatives of formula (I):

wherein R3, R4, R5, R6, R7, P, Q, V, W, X, Y, Z and a a...

12/18/2008
20080271678Adjustable Animal Watering System
The assemblies of the invention are suitable for mounting to, or being an integral part of, an animal enclosure such that the height of a valve-controlled liquid outlet may be adjusted according to the changing needs of growing animals. The adjustable liquid delivery as...
11/06/2008
20080241193CANINE LEISHMANIA VACCINE
The present invention provides vectors that contain and express in vivo Leishmania KMP11 or an epitope thereof that elicits an immune response in a dog against Leishmania, compositions comprising said vectors, methods of vaccination against Leishmania
10/02/2008
20080220022Salmonella Vaccine
The present invention relates to the field of vaccination against Salmonella in animals, particularly avian animals. The present invention also encompasses kits and uses of Salmonella immunogenic compositions or vaccines. The present invention further rela...
09/11/2008
20080187555New Vaccine Formulations
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified or weakly purified. The emulsion of the present invention can act as vehicl...
08/07/2008
20080177223Multiple Fluid Delivery Device For Poultry
The present invention provides an injection delivery system for the injection delivery of at least two fluid doses to a small bird by penetrating the skin of the recipient bird with at least on injection needle. The present injection delivery system comprises an injecti...
07/24/2008
20080108137Dispersion Devices For Aggregates
The present invention encompasses a flow-through dispersion device for the dispersion of cell aggregates, the device comprising a first or upstream inlet obstacle and a second or downstream outlet obstacle, each obstacle having at least one traversing hole wherein no tw...
05/08/2008
20060073594Chimeric vectors
The present invention relates to chimeric vectors. More specifically, the invention relates to recombinant poxvirus vectors and viruses that are capable of expressing an alphaviral RNA replicon expressing a heterologous sequence of interest. ...
04/06/2006
20060046988Methoprene formulations for the control of tick infestations
The present invention relates to a composition and process, in particular for controlling ticks on animals, characterized in that the composition includes, on the one hand, at least one compound of IGR (insect growth regulator) type, in doses and proportions which are p...
03/02/2006
20050287672Avipox recombinants expressing foot and mouth disease virus genes
The present invention relates to modified poxviral vectors and to methods of making and using the same. In particular, the invention relates to recombinant avipox that expresses gene products of foot and mouth disease virus (FMDV), and to compositions or vaccines that e...
12/29/2005
20050263079Methods and apparatus for automatic jet injection of bird eggs
An in ovo jet injection apparatus and related methods for treating live eggs. The jet injection apparatus includes one or more jet injection delivery devices configured to deliver one or more treatment substances to predetermined areas of eggs using a high pressure stre...
12/01/2005
20050214316Methods of characterizing infectious bursal disease virus
Characterization of infectious bursal disease virus (“IBDV”) for use in vaccine identification and production that provides rapid selection of a specific vaccine strain with an IBDV sequence most related to the IBDV of interest or identification of a novel strain of...
09/29/2005
20050202484Leptin promoter polymorphisms and uses thereof
The present invention relates to single nucleotide polymorphisms (SNPs) in the leptin promoter, and to methods for the identification of animals carrying specific alleles of these SNPs that are associated with circulating leptin levels, feed intake, growth rate, body we...
09/15/2005
20050142560Method for identifying and managing livestock by genotype
The present invention provides for a direct correlation between the rate of a feed conversion in livestock animals and the presence of alleles of a gene encoding an adipocyte-specific polypeptide, termed leptin, which gene is hereinafter referred to as ob. The invention...
06/30/2005
20050136087Stabilized formulation of ivermectin feed premix with an extended shelf life and method of making the same
The invention relates to a stabilized premix feed or feed-like formulation that has an extended shelf life due to a decrease of the degradates of the active ingredient by controlling the amount of an already existing stabilizer in the formulation. The feed premix is use...
06/23/2005
20050106163Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
Combination compositions including C. parvum antigen(s) or epitope(s) of interest with at least one other antigen or epitope of interest from a pathogen that causes enteric infection and/or symptoms and/or recombinant(s) and/or vector(s) and/or plasmid(s) express...
05/19/2005
1    
 
Sign InRegister
Username  
Password   
forgot password?